Directori de persones
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grau: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Grups

Publicacions

  • Bergadà L; Pallares J; Arcidiacono MV; Cardus A; Santacana M; Valls J; Cao G; Fernàndez E; Dolcet X; Dusso AS; Matias-Guiu X

    Role of local bioactivation of vitamin D by CYP27A1 and CYP2R1 in the control of cell growth in normal endometrium and endometrial carcinoma

    LABORATORY INVESTIGATION 94 608-622. .

    [doi:10.1038/labinvest.2014.57]

  • Muniesa, M.J.; González, S.; Buetas, P.; López, S.; Sánchez, C.; Matias-Guiu, X.

    Estudio del epitelio conjuntival de las ampollas filtrantes mediante citología de impresión.

    Archivos De La Sociedad Española De Oftalmología 89 216-221. .

    [doi:10.1016/j.oftal.2013.07.004]

  • Micci F; Gorunova L; Gatius S; Matias-Guiu X; Davidson B; Heim S; Panagopoulos I

    MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma

    CANCER LETTERS 347 75-78. .

    [doi:10.1016/j.canlet.2014.01.030]

  • Croner RS; Geppert CI; Bader FG; Nitsche U; Späth C; Rosenberg R; Zettl A; Matias-Guiu X; Tarragona J; Güller U; Stürzl M; Zuber M

    Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study

    BRITISH JOURNAL OF CANCER 110 2544-2550. .

    [doi:10.1038/bjc.2014.170]

  • Eritja N; Domingo M; Dosil MA; Mirantes C; Santacana M; Valls J; Llombart-Cussac A; Matias-Guiu X; Dolcet X

    Combinatorial Therapy Using Dovitinib and ICI182.780 (Fulvestrant) Blocks Tumoral Activity of Endometrial Cancer Cells

    MOLECULAR CANCER THERAPEUTICS 13 776-787. .

    [doi:10.1158/1535-7163.MCT-13-0794]

  • Espinosa, I; Catasus, L; D' Angelo E; Mozos, A; Pedrola, N; Bertolo, C; Ferrer, I; Zannoni, GF; West, RB; van de Rijn, M; Matias-Guiu, X; Prat, J

    Stromal signatures in endometrioid endometrial carcinomas

    Modern Pathology 27 631-639. .

    [doi:10.1038/modpathol.2013.131]

  • Bergadà L; Yeramian A; Sorolla A; Matias-Guiu X; Dolcet X

    Antioxidants Impair Anti-Tumoral Effects of Vorinostat, but Not Anti-Neoplastic Effects of Vorinostat and Caspase-8 Downregulation

    PLOS ONE 9 -. .

    [doi:10.1371/journal.pone.0092764]

  • Matias-Guiu X; De Lellis R

    Medullary Thyroid Carcinoma: a 25-Year Perspective

    ENDOCRINE PATHOLOGY 25 21-29. .

    [doi:10.1007/s12022-013-9287-2]

  • Matias-Guiu X; Davidson B

    Prognostic biomarkers in endometrial and ovarian carcinoma

    VIRCHOWS ARCHIV 464 315-331. .

    [doi:10.1007/s00428-013-1509-y]

  • Maiques O; Santacana M; Valls J; Pallares J; Mirantes C; Gatius S; García Dios DA; Amant F; Pedersen HC; Dolcet X; Matias-Guiu X

    Optimal protocol for PTEN immunostaining; role of analytical and preanalyticat variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues

    HUMAN PATHOLOGY 45 522-532. .

    [doi:10.1016/j.humpath.2013.10.018]

  • García-Carbonero R; Vilardell F; Jiménez-Fonseca P; González-Campora R; González E; Cuatrecasas M; Capdevila J; Aranda I; Barriuso J; Matías-Guiu X

    Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    CLINICAL & TRANSLATIONAL ONCOLOGY 16 243-256. .

    [doi:10.1007/s12094-013-1062-9]

  • Santacana, M; Maiques, O; Valls, J; Gatius, S; Lopez-Garcia, MA; Palacios, J; Dolcet, X; Matias-Guiu, X

    Immunohistochemical Profiling in Assessing Histological Type in Endometrial Carcinoma

    Modern Pathology 27 304-304. .

Projectes

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU